We present the case of a man in his 70s who developed acute confusion from hypertensive encephalopathy triggered by indomethacin. He was recently prescribed indomethacin, a non-steroidal anti-inflammatory drug (NSAID) for headaches. However, his headaches were in the context of worsening hypertension that was treated with trandolapril. The use of indomethacin consequently worsened his underlying condition. On presentation to the emergency department, his blood pressure was 190/110 mmHg. Bloodwork including electrolytes, glucose, metabolic studies, renal and liver function were within normal limits; infectious workup including blood and urine cultures subsequently returned negative; and brain computed tomography and magnetic resonance imaging revealed no acute process to explain his presentation. Indomethacin was discontinued and the patient's hypertension was treated with amlodipine. Both his confusion and underlying headaches resolved as his blood pressure normalized. The patient was diagnosed with hypertensive encephalopathy triggered by indomethacin. NSAID use can trigger blood pressure decompensation, especially in patients with underlying hypertension; this effect is particularly pronounced in patients treated with anti-hypertensive medications that inhibit the renin-angiotensin-aldosterone (RAS) system. Symptomatic treatment with NSAIDs is not without potential harm; it is important to carefully consider a patient's underlying diagnosis, indication for therapy and risk for adverse effects.
{"title":"Hypertensive Encephalopathy Triggered by Indomethacin Use","authors":"Jane Plitman, Vanessa Raco, Peter E. Wu","doi":"10.1002/ccr3.9604","DOIUrl":"https://doi.org/10.1002/ccr3.9604","url":null,"abstract":"<p>We present the case of a man in his 70s who developed acute confusion from hypertensive encephalopathy triggered by indomethacin. He was recently prescribed indomethacin, a non-steroidal anti-inflammatory drug (NSAID) for headaches. However, his headaches were in the context of worsening hypertension that was treated with trandolapril. The use of indomethacin consequently worsened his underlying condition. On presentation to the emergency department, his blood pressure was 190/110 mmHg. Bloodwork including electrolytes, glucose, metabolic studies, renal and liver function were within normal limits; infectious workup including blood and urine cultures subsequently returned negative; and brain computed tomography and magnetic resonance imaging revealed no acute process to explain his presentation. Indomethacin was discontinued and the patient's hypertension was treated with amlodipine. Both his confusion and underlying headaches resolved as his blood pressure normalized. The patient was diagnosed with hypertensive encephalopathy triggered by indomethacin. NSAID use can trigger blood pressure decompensation, especially in patients with underlying hypertension; this effect is particularly pronounced in patients treated with anti-hypertensive medications that inhibit the renin-angiotensin-aldosterone (RAS) system. Symptomatic treatment with NSAIDs is not without potential harm; it is important to carefully consider a patient's underlying diagnosis, indication for therapy and risk for adverse effects.</p>","PeriodicalId":10327,"journal":{"name":"Clinical Case Reports","volume":"12 11","pages":""},"PeriodicalIF":0.6,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.9604","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142674350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ammad Javaid Chaudhary, Taher Jamali, Abdullah Sohail, Christian E. Keller, Allyce Caines, Mazen ELatrache
In post-liver transplant patients, esophagitis presents a diagnostic and management challenge due to the potential for opportunistic infections. This case describes a 59-year-old female with primary sclerosing cholangitis who underwent orthotopic liver transplantation six years prior. She presented with dysphagia, and her medical history included immunosuppression with prednisone, tacrolimus, and mycophenolate and a history of achalasia treated with esophageal peroral endoscopic myotomy. Esophagogastroduodenoscopy (EGD) revealed severe esophagitis with extensive ulcerations, raising suspicion for infectious etiologies such as cytomegalovirus (CMV) and herpes simplex virus-1 (HSV-1). The biopsy confirmed a rare coinfection of CMV and HSV-1, which was characterized histologically by viral cytopathic effects and immunohistochemical staining. Treatment with valganciclovir and temporary cessation of mycophenolate led to symptom resolution and viral clearance. Follow-up EGD demonstrated healing of esophageal ulcers, with subsequent findings of Candida esophagitis but no evidence of CMV or HSV recurrence. This case highlights the importance of early endoscopic evaluation and biopsy in immunocompromised patients with esophagitis. CMV and HSV-1 coinfection, while rare, should be considered in this population due to its association with severe complications such as perforation and bleeding. Timely antiviral therapy and immunosuppression adjustment are critical for favorable outcomes.
{"title":"Esophagitis in a Post-Liver Transplant Patient: A Case of Cytomegalovirus and Herpes Simplex Virus-1 Coinfection","authors":"Ammad Javaid Chaudhary, Taher Jamali, Abdullah Sohail, Christian E. Keller, Allyce Caines, Mazen ELatrache","doi":"10.1002/ccr3.9565","DOIUrl":"https://doi.org/10.1002/ccr3.9565","url":null,"abstract":"<p>In post-liver transplant patients, esophagitis presents a diagnostic and management challenge due to the potential for opportunistic infections. This case describes a 59-year-old female with primary sclerosing cholangitis who underwent orthotopic liver transplantation six years prior. She presented with dysphagia, and her medical history included immunosuppression with prednisone, tacrolimus, and mycophenolate and a history of achalasia treated with esophageal peroral endoscopic myotomy. Esophagogastroduodenoscopy (EGD) revealed severe esophagitis with extensive ulcerations, raising suspicion for infectious etiologies such as cytomegalovirus (CMV) and herpes simplex virus-1 (HSV-1). The biopsy confirmed a rare coinfection of CMV and HSV-1, which was characterized histologically by viral cytopathic effects and immunohistochemical staining. Treatment with valganciclovir and temporary cessation of mycophenolate led to symptom resolution and viral clearance. Follow-up EGD demonstrated healing of esophageal ulcers, with subsequent findings of Candida esophagitis but no evidence of CMV or HSV recurrence. This case highlights the importance of early endoscopic evaluation and biopsy in immunocompromised patients with esophagitis. CMV and HSV-1 coinfection, while rare, should be considered in this population due to its association with severe complications such as perforation and bleeding. Timely antiviral therapy and immunosuppression adjustment are critical for favorable outcomes.</p>","PeriodicalId":10327,"journal":{"name":"Clinical Case Reports","volume":"12 11","pages":""},"PeriodicalIF":0.6,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.9565","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142674351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Arterial occlusive events (AOE) are rare adverse event in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor such as ponatinib. We treated a 47-year-old woman with chronic myeloid leukemia. She was failed to achieve optimal molecular response in prior two lines tyrosine kinase inhibitors treatment (dasatinib and bosutinib) for first 30 months. Finally, she was treated with ponatinib and achieve complete molecular remission in 28 months. However, she was suffered from AOE, in bilateral stenosis of the middle cerebral arteries. The patient's responsible vascular lesions of AOE were atypical site rather than usually affected lesions in common arteriosclerosis.
{"title":"Arterial Occlusive Events in a Patient With Chronic Myeloid Leukemia Treated With Ponatinib","authors":"Osamu Imataki, Makiko Uemura","doi":"10.1002/ccr3.9597","DOIUrl":"https://doi.org/10.1002/ccr3.9597","url":null,"abstract":"<p>Arterial occlusive events (AOE) are rare adverse event in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor such as ponatinib. We treated a 47-year-old woman with chronic myeloid leukemia. She was failed to achieve optimal molecular response in prior two lines tyrosine kinase inhibitors treatment (dasatinib and bosutinib) for first 30 months. Finally, she was treated with ponatinib and achieve complete molecular remission in 28 months. However, she was suffered from AOE, in bilateral stenosis of the middle cerebral arteries. The patient's responsible vascular lesions of AOE were atypical site rather than usually affected lesions in common arteriosclerosis.</p>","PeriodicalId":10327,"journal":{"name":"Clinical Case Reports","volume":"12 11","pages":""},"PeriodicalIF":0.6,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.9597","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142679911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p>A 19-year-old male with no known medical comorbidities presented to the emergency department with a dry cough and shortness of breath for 3 months. His heart rate was 114/min, respiratory rate was 32/min, blood pressure was 110/80 mmHg, temperature was 101.5 °F, and oxygen saturation was 86% on room air. Initial laboratory data were normal, and a serum Quantiferon test was positive. Computed tomography (CT) of the chest showed bilateral diffuse miliary infiltrates and ground-glass opacities (GGO), with mild bronchiectasis in the left upper lobe (Figure 1A). He required heated high-flow oxygen in the emergency department; however, he was intubated due to worsening respiratory failure and increased work of breathing. Bronchoscopy with bronchoalveolar lavage (BAL) was performed. BAL and tracheal aspirates were negative for <i>Mycobacterium tuberculosis</i> (MTB) polymerase chain reaction (PCR), acid-fast bacilli (AFB), bacterial, and fungal cultures. He remained on mechanical ventilation for 1 week, and all his cultures were negative. A second bronchoscopy with transbronchial cryobiopsy (TBLC) was performed to obtain a tissue diagnosis. TBLC revealed caseating granulomas and multinucleated giant cells (Figure 1B). Grocott's methenamine silver stain was negative. Tissue AFB cultures and MTB PCR obtained via TBLC came back positive for tuberculosis within 1 week. The patient was started on rifampin, isoniazid, pyrazinamide, and ethambutol for a 6-month course. He required a tracheostomy 16 days after mechanical ventilation and was able to wean off mechanical ventilation, being successfully decannulated 2 weeks after the tracheostomy.</p><p>Miliary tuberculosis is a life-threatening hematogenous dissemination of <i>Mycobacterium tuberculosis</i> bacilli. The diagnosis of pulmonary tuberculosis is determined by symptoms, risk factors, sputum smear microscopy, and chest radiography. In miliary TB, acid-fast bacilli (AFB) smears are positive in only 20%–25% of cases, and cultures of sputum are positive in 30%–65% of patients [<span>1</span>]. Transbronchial biopsy diagnostic yields are 62.5%–76% [<span>2</span>]. TBLC has been widely used for the diagnosis of interstitial lung disease. However, the role of TBLC in the diagnosis of culture-negative miliary TB remains unclear. There is limited data on the use of TBLC in culture-negative miliary TB. A case report by Nasu et al. [<span>3</span>] demonstrated the utility of TBLC in diagnosing miliary tuberculosis that initially mimicked hypersensitivity pneumonitis. In this case, cryobiopsy specimens revealed necrotic granulomas, which led to a re-examination of sputum and subsequent identification of <i>Mycobacterium tuberculosis</i>. The patient described in our case had ground-glass opacities (GGO), a rare presentation of miliary TB. Furthermore, sputum and BAL AFB cultures, as well as MTB PCR, were negative. Additionally, Sánchez-Cabral et al. highlighted the diagnostic value of TBLC in non-interstitial
{"title":"Transbronchial Cryobiopsy for the Diagnosis of Culture Negative Miliary Tuberculosis","authors":"Atif Saleem Siddiqui","doi":"10.1002/ccr3.9595","DOIUrl":"https://doi.org/10.1002/ccr3.9595","url":null,"abstract":"<p>A 19-year-old male with no known medical comorbidities presented to the emergency department with a dry cough and shortness of breath for 3 months. His heart rate was 114/min, respiratory rate was 32/min, blood pressure was 110/80 mmHg, temperature was 101.5 °F, and oxygen saturation was 86% on room air. Initial laboratory data were normal, and a serum Quantiferon test was positive. Computed tomography (CT) of the chest showed bilateral diffuse miliary infiltrates and ground-glass opacities (GGO), with mild bronchiectasis in the left upper lobe (Figure 1A). He required heated high-flow oxygen in the emergency department; however, he was intubated due to worsening respiratory failure and increased work of breathing. Bronchoscopy with bronchoalveolar lavage (BAL) was performed. BAL and tracheal aspirates were negative for <i>Mycobacterium tuberculosis</i> (MTB) polymerase chain reaction (PCR), acid-fast bacilli (AFB), bacterial, and fungal cultures. He remained on mechanical ventilation for 1 week, and all his cultures were negative. A second bronchoscopy with transbronchial cryobiopsy (TBLC) was performed to obtain a tissue diagnosis. TBLC revealed caseating granulomas and multinucleated giant cells (Figure 1B). Grocott's methenamine silver stain was negative. Tissue AFB cultures and MTB PCR obtained via TBLC came back positive for tuberculosis within 1 week. The patient was started on rifampin, isoniazid, pyrazinamide, and ethambutol for a 6-month course. He required a tracheostomy 16 days after mechanical ventilation and was able to wean off mechanical ventilation, being successfully decannulated 2 weeks after the tracheostomy.</p><p>Miliary tuberculosis is a life-threatening hematogenous dissemination of <i>Mycobacterium tuberculosis</i> bacilli. The diagnosis of pulmonary tuberculosis is determined by symptoms, risk factors, sputum smear microscopy, and chest radiography. In miliary TB, acid-fast bacilli (AFB) smears are positive in only 20%–25% of cases, and cultures of sputum are positive in 30%–65% of patients [<span>1</span>]. Transbronchial biopsy diagnostic yields are 62.5%–76% [<span>2</span>]. TBLC has been widely used for the diagnosis of interstitial lung disease. However, the role of TBLC in the diagnosis of culture-negative miliary TB remains unclear. There is limited data on the use of TBLC in culture-negative miliary TB. A case report by Nasu et al. [<span>3</span>] demonstrated the utility of TBLC in diagnosing miliary tuberculosis that initially mimicked hypersensitivity pneumonitis. In this case, cryobiopsy specimens revealed necrotic granulomas, which led to a re-examination of sputum and subsequent identification of <i>Mycobacterium tuberculosis</i>. The patient described in our case had ground-glass opacities (GGO), a rare presentation of miliary TB. Furthermore, sputum and BAL AFB cultures, as well as MTB PCR, were negative. Additionally, Sánchez-Cabral et al. highlighted the diagnostic value of TBLC in non-interstitial","PeriodicalId":10327,"journal":{"name":"Clinical Case Reports","volume":"12 11","pages":""},"PeriodicalIF":0.6,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.9595","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142674352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Autoimmune pulmonary alveolar proteinosis (PAP) is characterized by antibodies to granulocyte–macrophage colony-stimulating factor (GM-CSF), alveolar macrophage dysfunction, and surfactant accumulation. Whole lung lavage (WLL) is the treatment of choice in patients with PAP and severe hypoxemia. In resource-limited settings, WLL can be performed in the intubated, anesthetized patient who is being one lung ventilated using a Y-type bladder irrigation catheter for saline instillation and drainage.
自身免疫性肺泡蛋白沉积症(PAP)的特征是粒细胞-巨噬细胞集落刺激因子(GM-CSF)抗体、肺泡巨噬细胞功能障碍和表面活性物质积聚。全肺灌洗(WLL)是治疗 PAP 和严重低氧血症患者的首选方法。在资源有限的情况下,全肺灌洗可在插管麻醉的单肺通气患者中进行,使用 Y 型膀胱灌注导管进行生理盐水的灌注和引流。
{"title":"Whole Lung Lavage in Autoimmune Pulmonary Alveolar Proteinosis: Unique Challenges in a Resource-Limited Setting","authors":"Ashesh Dhungana, Buddhi Sagar Lamichhane, Prajowl Shrestha, Deepa Kumari Shrestha, Ritamvara Oli, Shreya Dhungana, Pratibha Bista","doi":"10.1002/ccr3.9588","DOIUrl":"https://doi.org/10.1002/ccr3.9588","url":null,"abstract":"<p>Autoimmune pulmonary alveolar proteinosis (PAP) is characterized by antibodies to granulocyte–macrophage colony-stimulating factor (GM-CSF), alveolar macrophage dysfunction, and surfactant accumulation. Whole lung lavage (WLL) is the treatment of choice in patients with PAP and severe hypoxemia. In resource-limited settings, WLL can be performed in the intubated, anesthetized patient who is being one lung ventilated using a Y-type bladder irrigation catheter for saline instillation and drainage.</p>","PeriodicalId":10327,"journal":{"name":"Clinical Case Reports","volume":"12 11","pages":""},"PeriodicalIF":0.6,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.9588","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142674204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}